XML 75 R47.htm IDEA: XBRL DOCUMENT v3.24.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2024
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents, and restricted cash in the balance sheets that sum to the total of the same such amounts shown in the statements of cash flows (in thousands):
December 31,
20232022
Cash and cash equivalents$148,210 $82,021 
Restricted cash508 — 
Total cash, cash equivalents and restricted cash$148,718 $82,021 
The following table provides a reconciliation of cash, cash equivalents, and restricted cash in the balance sheets that sum to the total of the same such amounts shown in the statements of cash flows (in thousands):
September 30,
2024
December 31,
2023
Cash and cash equivalents$66,633 $148,210 
Restricted cash339 508 
Total cash, cash equivalents and restricted cash$66,972 $148,718 
Restrictions on Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents, and restricted cash in the balance sheets that sum to the total of the same such amounts shown in the statements of cash flows (in thousands):
December 31,
20232022
Cash and cash equivalents$148,210 $82,021 
Restricted cash508 — 
Total cash, cash equivalents and restricted cash$148,718 $82,021 
The following table provides a reconciliation of cash, cash equivalents, and restricted cash in the balance sheets that sum to the total of the same such amounts shown in the statements of cash flows (in thousands):
September 30,
2024
December 31,
2023
Cash and cash equivalents$66,633 $148,210 
Restricted cash339 508 
Total cash, cash equivalents and restricted cash$66,972 $148,718 
Property, Plant and Equipment The cost of property and equipment costs are depreciated on the straight-line method over the following estimated useful lives:
TypeEstimated useful
life
Lab equipment5 years
Manufacturing equipment10 years
Leasehold improvementsLesser of the remaining economic life of the
asset or the lease-term
Furniture and fixtures5 years
Software3 years
Property and equipment consist of the following (in thousands):
December 31,
20232022
Lab equipment$3,144 $3,088 
Manufacturing equipment6,142 5,955 
Leasehold improvements15,376 15,298 
Office equipment19 — 
Software268 289 
Construction in progress234 252 
Total property and equipment, cost25,183 24,882 
Less accumulated depreciation and amortization(8,009)(4,767)
Property and equipment, net$17,174 $20,115 
Property and equipment, net consist of the following (in thousands):
September 30,
2024
December 31,
2023
Lab equipment$3,244 $3,144 
Manufacturing equipment6,326 6,142 
Office Equipment19 19 
Leasehold improvements15,396 15,376 
Software268 268 
Construction in progress1,202 234 
Total property and equipment, cost26,455 25,183 
Less accumulated depreciation(10,387)(8,009)
Property and equipment, net$16,068 $17,174 
Schedule of Earnings Per Share, Basic and Diluted
The following table sets forth the computation of basic and diluted net income (loss) per share (in thousands, except share and per share amounts):
Year Ended December 31, 2023Year Ended December 31, 2022
Pre-Merger (1)
Post-Merger (2)
Pre-Merger (1)
Class AClass BCommon stockClass AClass B
Net income (loss) per share, basic:
Numerator:
Net income (loss)$(49,971)$— $13,654 $(55,189)$— 
Denominator:
Weighted-average shares outstanding used in computing net income (loss) per share, basic426,097491,867394,533
Net income (loss) per share, basic$(117.28)$— $27.76 $(139.88)$— 
Net income (loss) per share, diluted:
Numerator:
Net income (loss)$(49,971)$— $13,654 $(55,189)$— 
Denominator:
Weighted-average shares outstanding used in computing net income (loss) per share, basic426,097491,867394,533
Weighted-average effect of dilutive securities:
Warrants to purchase common stock4,063,361
Options to purchase common stock101,719
Weighted-average shares outstanding used in computing net income (loss) per share, diluted426,0974,656,947394,533
Net income (loss) per share, diluted$(117.28)$— $2.93 $(139.88)$— 
__________________
(1) Represents the period starting January 1, 2023 through Closing for the year ended December 31, 2023 and for the year ended December 31, 2022.
(2) Represents the period subsequent to Closing (December 18, 2023) through December 31, 2023.
The following table sets forth the computation of basic and diluted net loss per share (in thousands, except share amounts):
Nine Months Ended September 30,
20242023
Common stockClass AClass B
Numerator:
Net loss$(55,630)$(38,700)$— 
Denominator:
Weighted-average shares outstanding in computing net loss per share, basic and diluted16,932,976441,498— 
Net loss per share, basic and diluted$(3.29)$(87.66)$— 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
Potentially dilutive securities that were not included in the diluted per share calculations because they would be antidilutive were as follows:
Year Ended December 31, 2023Year Ended December 31, 2022
Pre-Merger (1)
Post-Merger (2)
Pre-Merger (1)
Class AClass BCommon stockClass AClass B
Options to purchase common stock614,729 — 541,180 468,632 — 
Restricted stock awards— — — 6,691 — 
Series A-1 convertible preferred stock (3)
— — — 18,604,653 — 
Series A-2 convertible preferred stock (3)
— — — 13,291,208 — 
Series B convertible preferred stock (3)
— — — 74,405,719 — 
Total awards excluded614,729 — 541,180 106,776,903 — 
__________________
(3)The convertible preferred stock does not reflect the application of the 0.0756 Exchange Ratio.
The following potentially dilutive securities have been excluded from the diluted per share calculations as they would be anti-dilutive:
Nine Months Ended September 30,
20242023
Series A-1 convertible preferred stock (1)
— 18,604,653
Series A-2 convertible preferred stock (1)
— 13,291,208
Series B convertible preferred stock (1)
— 74,405,719
Stock options1,384,182609,656
Total1,384,182106,911,236
__________________
The convertible preferred stock does not reflect the application of the 0.0756 Exchange Ratio.